Literature DB >> 34459397

Pre-Statistical Considerations for Harmonization of Cognitive Instruments: Harmonization of ARIC, CARDIA, CHS, FHS, MESA, and NOMAS.

Emily M Briceño1,2,3, Alden L Gross4, Bruno J Giordani5,6, Jennifer J Manly7,8, Rebecca F Gottesman9, Mitchell S V Elkind7,10, Stephen Sidney11, Stephanie Hingtgen12, Ralph L Sacco13, Clinton B Wright14, Annette Fitzpatrick15, Alison E Fohner15, Thomas H Mosley16, Kristine Yaffe17, Deborah A Levine2,3,12,18.   

Abstract

BACKGROUND: Meta-analyses of individuals' cognitive data are increasing to investigate the biomedical, lifestyle, and sociocultural factors that influence cognitive decline and dementia risk. Pre-statistical harmonization of cognitive instruments is a critical methodological step for accurate cognitive data harmonization, yet specific approaches for this process are unclear.
OBJECTIVE: To describe pre-statistical harmonization of cognitive instruments for an individual-level meta-analysis in the blood pressure and cognition (BP COG) study.
METHODS: We identified cognitive instruments from six cohorts (the Atherosclerosis Risk in Communities Study, Cardiovascular Health Study, Coronary Artery Risk Development in Young Adults study, Framingham Offspring Study, Multi-Ethnic Study of Atherosclerosis, and Northern Manhattan Study) and conducted an extensive review of each item's administration and scoring procedures, and score distributions.
RESULTS: We included 153 cognitive instrument items from 34 instruments across the six cohorts. Of these items, 42%were common across ≥2 cohorts. 86%of common items showed differences across cohorts. We found administration, scoring, and coding differences for seemingly equivalent items. These differences corresponded to variability across cohorts in score distributions and ranges. We performed data augmentation to adjust for differences.
CONCLUSION: Cross-cohort administration, scoring, and procedural differences for cognitive instruments are frequent and need to be assessed to address potential impact on meta-analyses and cognitive data interpretation. Detecting and accounting for these differences is critical for accurate attributions of cognitive health across cohort studies.

Entities:  

Keywords:  Cognition; dementia; epidemiology; methods

Mesh:

Year:  2021        PMID: 34459397      PMCID: PMC8733857          DOI: 10.3233/JAD-210459

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.160


  16 in total

1.  Toward an integrative science of life-span development and aging.

Authors:  Scott M Hofer; Andrea M Piccinin
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2010-03-17       Impact factor: 4.077

2.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

3.  Calibration and validation of an innovative approach for estimating general cognitive performance.

Authors:  Alden L Gross; Richard N Jones; Tamara G Fong; Douglas Tommet; Sharon K Inouye
Journal:  Neuroepidemiology       Date:  2014-01-28       Impact factor: 3.282

4.  Parallel but not equivalent: challenges and solutions for repeated assessment of cognition over time.

Authors:  Alden L Gross; Sharon K Inouye; George W Rebok; Jason Brandt; Paul K Crane; Jeanine M Parisi; Doug Tommet; Karen Bandeen-Roche; Michelle C Carlson; Richard N Jones
Journal:  J Clin Exp Neuropsychol       Date:  2012-04-30       Impact factor: 2.475

5.  Statistical approaches to harmonize data on cognitive measures in systematic reviews are rarely reported.

Authors:  Lauren E Griffith; Edwin van den Heuvel; Isabel Fortier; Nazmul Sohel; Scott M Hofer; Hélène Payette; Christina Wolfson; Sylvie Belleville; Meghan Kenny; Dany Doiron; Parminder Raina
Journal:  J Clin Epidemiol       Date:  2014-12-08       Impact factor: 6.437

6.  Modeling life-span growth curves of cognition using longitudinal data with multiple samples and changing scales of measurement.

Authors:  John J McArdle; Kevin J Grimm; Fumiaki Hamagami; Ryan P Bowles; William Meredith
Journal:  Psychol Methods       Date:  2009-06

7.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

8.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

9.  CARDIA: study design, recruitment, and some characteristics of the examined subjects.

Authors:  G D Friedman; G R Cutter; R P Donahue; G H Hughes; S B Hulley; D R Jacobs; K Liu; P J Savage
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

10.  Sex Differences in Cognitive Decline Among US Adults.

Authors:  Deborah A Levine; Alden L Gross; Emily M Briceño; Nicholas Tilton; Bruno J Giordani; Jeremy B Sussman; Rodney A Hayward; James F Burke; Stephanie Hingtgen; Mitchell S V Elkind; Jennifer J Manly; Rebecca F Gottesman; Darrell J Gaskin; Stephen Sidney; Ralph L Sacco; Sarah E Tom; Clinton B Wright; Kristine Yaffe; Andrzej T Galecki
Journal:  JAMA Netw Open       Date:  2021-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.